ARTICLE | Clinical News
Adderall XR regulatory update
October 15, 2001 7:00 AM UTC
SHP received FDA marketing approval for its Adderall XR once-daily treatment for attention deficit hyperactivity disorder (ADHD). The product uses SHP's Microtrol bead delayed-release drug delivery te...